KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ACM Research (ACMR) Cash & Equivalents (2016 - 2025)

ACM Research (ACMR) has disclosed Cash & Equivalents for 10 consecutive years, with $757.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 85.88% to $757.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $757.4 million, a 85.88% increase, with the full-year FY2025 number at $757.4 million, up 85.88% from a year prior.
  • Cash & Equivalents was $757.4 million for Q4 2025 at ACM Research, down from $1.1 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.1 billion in Q3 2025 to a low of $64.5 million in Q3 2021.
  • A 5-year average of $348.2 million and a median of $324.2 million in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: soared 683.86% in 2021, then crashed 55.92% in 2022.
  • ACM Research's Cash & Equivalents stood at $562.5 million in 2021, then plummeted by 55.92% to $248.0 million in 2022, then decreased by 26.56% to $182.1 million in 2023, then surged by 123.76% to $407.4 million in 2024, then soared by 85.88% to $757.4 million in 2025.
  • Per Business Quant, the three most recent readings for ACMR's Cash & Equivalents are $757.4 million (Q4 2025), $1.1 billion (Q3 2025), and $442.1 million (Q2 2025).